Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis
Clinical trial NCT02243306 · COMPLETED
Trial details
- NCT number
- NCT02243306
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-24
- Primary completion
- 2017-05-10
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.